Article Details
Retrieved on: 2024-10-01 21:32:17
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Deltacel therapy, developed by Kiromic BioPharma, showing promising results in treating non-small-cell lung cancer (NSCLC) with progression-free survival and no adverse effects. It relates to biopharma through advanced medical treatment development.
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here